HEKİMLERİMİZ


Medicana Sağlık Grubu Hastaneleri, Tüm Branşlarda SGK Anlaşmalıdır.

+A A-

Prof. Dr. Salih Emri

Ad Soyad
Salih Emri
Unvan
Prof. Dr.
Tıbbi Birim
Göğüs Hastalıkları
Şube
MEDICANA KADIKÖY
Telefon
0216 970 49 70
E-Posta
salih.emri@medicana.com.tr
E-RANDEVU
Mezun Olduğu Tıp Fakültesi ve Yılı
Hacettepe Üniversitesi Tıp Fakültesi (1982)
Uzmanlık Eğitimi Aldığı Yer ve Yılı
Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıkları Uzmanı (1989)
Hacettepe Üniversitesi İç Hastalıkları Ana Bilim Dalı/Göğüs Hastalıkları Ünitesi Öğretim Görevlisi (1990)
Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıklar/Göğüs Hastalıkları Ünitesi Doçent (1991)
Hacettepe Üniversitesi Göğüs Hastalıkları Ana Bilim Dalı Kadrolu Doçent (1992)
Boston Üniversitesi Tıp Fakültesi Tıbbi Onkoloji Bölümü’nde Research Fellow (1993-1994)
Hacettepe Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Uzman (1995)
Hacettepe Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları Profesör (2012)
Mesleki Deneyim
Ordu/Gülyalı Sağlık Ocağı Ocak Hekimi ve Sağlık Müdür Yardımcılığı (1982-1984)
Hacettepe Üniversitesi İç Hastalıkları Ana Bilim Dalı Araştırma Görevlisi (1984-1989)
GATA Gastroenteroloji Kliniği İç Hastalıkları Uzman (1989 – 1990 Askerlik)
Hacettepe Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Öğretim Üyesi (1990-2016)
Hacettepe Üniversitesi Göğüs Hastalıkları Ana Bilim Dalı Başkanı (2012-2015)
Medicalpark Göztepe Hastanesi Göğüs Hastalıkları Uzmanı (2017-2018)
Altunbaş-Kemerburgaz Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Profösör (2017-2018)
Yeditepe Üniversitesi İhtisas Hastanesi Göğüs Hastalıkları Uzmanı (2018 – 2019)
Tıbbi İlgi Alanları

Akciğer ve Plevra Maliğniteleri
Hava Yolu Hastalıkları
Uykuda Solunum Bozuklukları
Girişimsel Bronkoloji
Diffüz Akciğer Hastalıkları ve Sarkoidoz
Nadir Görülen Akciğer Hastalıkları
Konjenital Akciğer Hastalıkları ve Kisitk Fibrozis
Pulmoner Hipertansiyon

Özellikli İşlem

Bilimsel Yayınlar

Uluslararası Yayınlar

Prof.Dr. Salih Emri’nin “uluslararası yayın” niteliğinde toplam 124 adet yayını vardır.
a) SCI,SCI-EXP kapsamındaki dergilerde toplam 37 adet makalesi vardır. Bu grupta “Simian vİrus 40 is not a Cofactor in the Pathogenesİs of Environmentally Induced Malİgnant Pleural Mesothelioma in Turkey” başlıklı yayını başlıca araştırma eseri olup, Anticancer Research dergisinde 2000 yılında yayınlanmıştır. Bu çalışmada Türkiye’de çevresel mineral lif temasına sekonder gelişmiş mezotelyoma dokularında SV40 virüsünün DNA sekansları bir TUBITAK projesi çerçevesinde araştırılmış ve bu virüsün Batı Ülkelerinin aksine Türkiye’de mezotelyoma patogenezinde bir kofaktör olmadığı sonucuna varılmıştır. Bu gruptaki yayınlarının 1’i hariç hepsi doçentlik sonrası döneme aittir.

1. Taşdemir I, Sivri B, Turgan Ç, Emri S, Yasavul U, and Çağlar Ş. The expanding
spectrum of a disease. Behçet’s disease associated with amyloidosis. Nephron 1989;
52: 154-157.

2. Selçuk ZT, Çöplü L, Emri S, Kalyoncu AF, Şahin AA, Barış Yİ. Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey.
Analysis of 135 cases. Chest 1992; 102: 790-796.

3. Akhan O, Demirkazık FB, Özmen MN, Balkancı F, Özkara Ş, Çöplü L, Emri S, and Besim A. Tuberculous pleural effusions: Ultrasonic diagnosis. J Clin Ultrasound 1992; 20: 461-465.

4. Şahin AA, Çöplü L, Selçuk ZT , Eryılmaz M, Emri S, Akhan O, Barış Yİ. Malignant pleural mesothelioma caused by environmental exposure to asbestos or erionite in rural Turkey:CT findings in 84 patients. AJR 1993; 161: 533-537.

5. Tansan T, Emri S, Selçuk T, Koç Y, Hesketh P, Heeren T, McCaffrey RP, and Barış Yİ. Treatment of Malignant Pleural Mesothelioma with Cisplatin, Mitomycin C and Alpha Interferon. Oncology 1994; 51: 348-351.

6. Kalyoncu AF, Selçuk ZT, Karakoca Y, Emri AS, Çöplü L, Şahin AA, and Barış Yİ.
Prevalence of childhood asthma and allergic disease in Ankara. Allergy 1994; 49: 485-488.

7. Idell S, Pueblitz S, Emri S, Güngen Y, Gray L, Kumar A, Holiday D, Koenig KB, and
Johnson AR. Regulation of Fibrin Deposition by Malignant Mesothelioma. Am J Pathol 1995; 147: 1318-1329.

8. Kalyoncu AF, Çöplü L, Selçuk ZT, Emri AS, Kolaçan B, Kocabaş A, Akkoçlu A, Erkan L, Şahin AA, and Barış Yi. Survey on the allerjik status of patients with bronchial asthma in Turkey: A multicenter study. Allergy 1995; 50: 451-455.

9. Shetty S, Kumar A, Pueblitz S, Emri S, Gungen Y, Johnson AR, and Idell S. Fibrinogen Promotes Adhesion of Monocytic to Human Mesothelioma Cells. Thromb Haemost 1996; 75: 782-790.

10. Özdemir O, Emri S, Karakoca Y, Sayınalp N, Akay H, Dündar S, and Barış Yİ. Fibrinolytic System in Plasma and Pleural Fluid in Malignant Pleural Mesothelioma. Thromb Res 1996; 84:121-128.

11. Kostakoglu L, Kıratlı P, Ruacan S, Hayran M, Emri S, Ergün EL, Bekdik CF.
Association of tumor washout rates and accumulation of technetium-99m-MIBI
with expression of P-glycoprotein in lung cancer. J Nucl Med 1988; 39: 228-234.

12. Dumortier P, Coplu L, Maertelaer V, Emri S, Barıi I, Vuyst PD. Assessment of environmental asbestos exposure in Turkey by bronchoalveolar lavage. Am J Respir Crit Care Med 1998; 158: 1815-1824.

13. Emri S, Bagcı T, Karakoca Y, Barış E. Recognition of cigarette brand names and logos by primary school children in Ankara. Tobacco Control 1998;7: 386-392.

14. Emri S, Kocagöz T, Olut A, Güngen Y, Mutti L, Baris YI. Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey. Anticancer Research 2000; 20: 891-894.

15. Atimtay AT, Emri S, Bagci T, Demir AU. Urban CO exposure and its health efects on traffic policemen in Ankara. Environmental Research 2000; 82: 222-230.

16. Emri S, Akbulut H, Zorlu F, Dinçol D, Akay H, Güngen Y, Icli F. Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma. Lung Cancer. 2001; 33: 109-114.

17. Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 2001;357:444-445.

18. Olut A, Firat P, Ertugrul D, Gungen Y, Emri S.Ras oncoprotein expression in erionite -and asbestos-induced Turkish malignancy pleural mesothelioma-a pilot study. Respiratory Medicine 2001;95:697-698.

19. Dumortier P, Coplu L, Broucke I, Emri S, Selcuk T, de Maertelaer V, De Vuyst P, Baris I.Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzkoy, Cappadocia, Turkey. Occup Environ Med 2001;58:261-266.

20. Jasani B, Cristaudo A, Emri SA, Gazdar AF, Gibbs A, Krynska B, Miller C, Mutti L, Radu C, Tognon M, Procopio A. Association of SV40 with human tumours.
Semin Cancer Biol 2001;11: 49-61. Review.
21. Emri S, Demir A, Dogan M, Akay H, Bozkurt B, Carbone M, Baris I. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicology Letters 2002;127: 251-257. Review.

22. Tomek S, Emri S, Krejcy K, Manegold C. Chemotherapy for malignant pleural mesothelioma: past results and recent developments. British Journal of Cancer 2003; 88: 167-174.

23. Emri S. Recent developments in the therapy of malignnat pleural mesothelioma. Indoor and Built Environment 2003;12:391-393(review)

24. Vogelzang NJ, Rusthoven J, Paoletti P, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer MJ, Emri S, Niyikiza C. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636-2644.

25. Emri S, Demir AU. Malignant pleural mesothelioma in Turkey, 2000-2002. Lung Cancer 2004;455: S17-S20.

26. Aslan D, Altıntaş H, Emri S, et al. Self-evaluations of tuberculosis patients about their illnesses at Ankara Ataturk Sanatorium Training and Research Hospital, Turkey. Respir Med 2004;98:626-631.

27. Kokturk N, Firat P, Akay H, Kadilar C, Ozturk C, Zorlu F, Gungen Y, Emri S. Prognostic significance of Bax and Fas Ligand in erionite and asbestos induced Turkish malignant plural mesothelioma. Lung Cancer 2005;50:189-198.

28. Dogan AU, Baris YI, Dogan M, Emri S, steele I, Elmishad AG, Carbone M. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res 2006;66:5063-5068.

29. Carbone M, Emri S, Dogan AU, Steele I, Tuncer M, Pass HI, Baris YI. A mesothelioma epidemic in Cappadocia:scientific developments and unexpected social outcomes. Nat Rev Cancer 2007; 2:147-154. Review.

30. Zorlu Af, Selek U, Emri S. Gurkaynak M, Akyol FH. Second line palliative endobronchial radiotherapy with HDR Ir 192 in recurrent lung carcinoma. Yonsei Med J 2008; 49: 620-624.

31. Hurmuz P, akyol F, Selek U, Ozyigit G, Dogan R, Ozdemir N, Tastepe I, Cangir AK, Kara M, Demirkazik FB, Emri S. The efficiency and toxicitiy of hemithoracic radiotherapy after extra pleural pneumonectomy in malignant pleural mesothelioma. UHOD 2010;20:20-26.

32. Bacanli S , Icen D , Emri S . Fuzzy approach of group sequential test for binomial case.
HACETTEPE JOURNAL OF MATHEMATICS AND STATISTICS, Volume: 43, Issue: 6 Pages: 1017-1034, 2014.

33. Emri S, Kilickap S, Kadilar C, Halil MG, Akay H, Besler T. Serum levels of alpha-tocopherol, vitamin C, beta-carotene, and retinol in malignant pleural mesothelioma. Asian Pac J Cancer Prev. 2012;13(7):3025-9.

34. Onder S, Guler G, Emri S, Fırat P. EGFR expression and gene copy number in malignant pleuraş mesothelioma in Turkey. UHOD-Uluslararası Hematoloji Onkoloji Dergisi 2012;22(3): 181-186.

35. Ybarra M, Bağci Bosi AT, Korchmaros J, Emri S. Correction: A Text Messaging-Based Smoking Cessation Program for Adult Smokers: Randomized Controlled Trial. J Med Internet Res. 2015 Jun 5;17(6):e125. doi: 10.2196/jmir.4655

36. Er M, Emri SA, Demir AU, Thorne PS, Karakoca Y, Bilir N, Barış Yİ. Byssinosis and COPD rates among factory workers manufacturing hemp and jute. Int J Occup Med Environ Health 2016;29(1):55–68 DOI: 10.13075/ijomeh.1896.00512.

37. Ozturk O, Sandal A, Karahan S, Er B, Onder S, Koksal D, Maden E, Emri S. Diagnostic yield of conventional transbronchial needle aspirat,on biopsy(C-TBNA) withoutan on site cytopathologist: Experience of 363 procedures in 219 patients.TUBERCULOSIS AND THORAX 2016,64:137-143,doı: 10.5578/TT.10905


Dergilerde Teknik Not, Vaka Takdimi

SCI, SCI-EXP kapsamındaki dergilerde kapsamındaki dergilerde 18 teknik not, vaka takdimi ve benzeri yazıları yayınlanmıştır.

1. Taşdemir I, Turgan Ç, Emri S, Yasavul U, Çağlar Ş, Bakkaloğlu M, Erkan I, and Erol D. Spontaneous perirenal haematoma secondary to polyarteritis nodosa. Br J
Urol 1988; 62, 219-222.

2. Emri S, Çöplü L, Selçuk ZT, Şahin AA, Barış Yİ. Hypertrophic pulmonary osteoarthropaty in a patient with pulmonary microlithiasis. Thorax 1991; 46:
145-146.

3. Coplu L, Emri S, Selçuk ZT, Kalyoncu F, Balkancı F,Şahin AA, Barış Yİ. Life threatening chylous pleural and pericardial effusion in a patient with Behçet’s syndrome. Thorax 1992; 47: 64-65.

4. Vuyst P, Dumortier P, Jacobovitz D, Emri S, Çöplü L,and Barış YI. Environmental asbestosis complicated by lung cancer. Chest 1994; 105: 1593-1595.

5. Ustündag Y, Emri S, Bayraktar Y. Superior vena cava thrombosis and obstructive sleep apnea in a patient with familian mediteranean fever. Am J Med Sci 1998; 316:53-55.

6. Aydın M, Emri S, Caner B. Tc-99m-pertechnetatte scintigraphy before and after potassium perchlorate administration for the diagnosis of retrosternal goiter. Clinical Nuclear Medicine 2000; 25: 467-468.

7. Usalan C, Emri S. Exertional dyspnea and nonproductive cough in a 22-year-old man. Postgrad Med J 2000; 76: 115-117.

8. Ariyurek MO, Karçaaltinbaca M, Demirkazik FB, Akay H, Gedikoglu G, Emri S. Bilateral multiple pulmonary tuberculous nodules mimicking metastatic disease. Eur J Radiol 2003; 44: 33-36.

9. Erdogan E, Demirkazık FB, Gulsun M, Ariyurek M, Emri S, Sak SD. Incidental localized (solitary) mediastinal malignant mesothelioma. Br J Radiol 2005; 78: 858-861.

10. Oyan B, Koc Y, Emri S, Kansu E. Improvement of Chronic pulmonary graft-vs-host disease manifesting as bronchiolitis obliterans organizing pneumonia following extracorporeal photopheresis. Medical Oncology 2006;23:125-129.

11. Hurmuz P, Zorlu F, Cansiz C, Emri S. Malignant pleural mesothelioma with brain metastasis. J BUON 2009; 14: 123-125.

12. Kara M, Onder S, Firat P, Emri S.A rare histological presentation of a common lung tumor: adenoleiomyomatous hamartoma. Acta Chir Belg 2012 Jan;112(1):74-6.

13. Tutluer S, Tanriover MD, Emri S.Systemic glucocorticoid and anti-tuberculosis therapy in a patient with coexisting tuberculosis and anthracosis. Sarcoidosis Vasc Diffuse Lung Dis 2013 Dec 17;30(4):308-11.

14. Koksal D. , Ibrahimov,F., Bugdayci M. Gedikoglu G., Emri, S. Primary diffuse pleural rhabdomyosarcoma in an adult patient (Article) . Asian Cardiovascular and Thoracic Annals,Volume 24, Issue 1, 1 January 2016, Pages 98-100.

15. Er B, Koksal D, Kalyoncu U, Ozmen O, Emiralioglu N, Yalcin EG, Ergun E, Emri S.Takayasu’s arteritis as the aetiology of unresolved fever in an adult patient with cystic fibrosis. Acta Clin Belg 2015 Aug;70(4):295-8. doi: 10.1179/2295333715Y.0000000013.

16. Esendagli D, Koksal D, Emri S. Recovery of pulmonary and skin lesions of sarcoidosis after tymectomy. Acta Clinica Belgica 2016, 71:441-443.

17. Ozturk O, Esendagli D, Yazici E, köksal D, Emri SK. Giant endotracheal thorombus: a rare cause of post-operative dyspnea. Tuberk Toraks 2016 64: 321-323.

18. Koksal D, Ulasli SS, Emri S. Medical thorascopy/pleuroscopy: is it underutizied? Eur Clin Respir J 2017; Jan 6;4(1):1270078.


SCI, SCI-EXP Kapsamındaki Dergilerde, Uluslararası Kongrelerde Sunuları

SCI, SCI-EXP kapsamındaki dergilerde 42 adet uluslararası kongrelerde sunuları özeti yayınlanmış bildiri ve editöre mektup niteliğinde yayını vardır.

1. Kalyoncu AF, Çöplü L, Emri AS. Indiscriminate prescribing of NSAID’s
(Letter to the editor). NZ Med J 1991; 11: 388.

2. Kalyoncu AF, Selcuk ZT, Emri AS, Çöplü L, Şahin AA, Bariş Yİ. Echinococcosis in the Middle Esat and Turkey (Letter to the editor). RID 1991; 13: 1028-1029.

3. Kalyoncu AF, Selçuk ZT, Iskendarani A, Çöplü L, Emri S, Şahin AA, and Barış Yİ. Alternative and complementary medicine for asthma (Letter to the editor).
Thorax 1992; 47: 762.

4. Şahin AA, Selçuk ZT, Kalyoncu AF, Çöplü L, Emri S, and Barış Yİ. Treatment of echinococcus granulosus cysts (Letter to the editor). Scand J Infect Dis 1993; 25: 269.

5. Emri S, Karakoca Y, Barış Yİ, Zorlu F, Akyol F, and Akay H. Preventive irradiation after invasive diagnostic and therapeutic procedures in malignant pleural mesothelioma (Letter to the editor). Chest 1996; 109: 1665-1666.

6. Emri S, Bagci T, Karakoca Y. Cigarette smoking habits among primary school
children in Turkey (Letter to editor). Chest 1997;112: 863-864.

7. Emri S. New legislation in Turkey (Letter to editor). Tobacco Control 1997; 6: 61.

8. Üstündag Y, Öksüzoglu G, Emri S, Kalyoncu F, Tatar G. Atopy and food allergy in varioliform gastritis. (Letter to the editor). J Clin Gastroenterol 1998;27: 275-276.

9. Selçuk ZT, Emri S, Şahin AA, Barış YI, Çöplü L, Kalyoncu F, Artvinli M. Malignant mesothelioma and erionite exposure. (Letter to the editor). Eur Respir J 1999; 14: 480-81.

10. Dogan AU, Baris YI, Emri S, Testa JR, Carbone M. Familial malignant mesothelioma (authors’reply). Lancet 2001; 358: 1813-1814.

11. Carbone M, Bocchetta M, Cristaudo A, Emri S, and et al. SV40 and human brain tumors (Letters to editor). Int J Cancer 2003; 106: 140-142.

12. Isıldak M, Guven GS, Emri S. Mesothelioma and venous thrombosis. (author reply) CMAJ 2004; 171: 11.

13. Barış I, Tansan S, Çöplü L, Hesketh P, Selçuk T, Mc Caffrey R, Emri S, Şahin A, and
Bernal S. Malignant mesothelioma related to erionite exposure in central Turkey. ASCO
1991; 10: 132.

14. Akhan O, Boyvat F, Emri S, Özmen M, Çöplü L, Arıyürek M, Eryılmaz M, and Barış İ. CT classification of pulmonary hydatid disease. Eur Respir J 1993; 6 (suppl 17): 557s.

15. Coplu l, Selcuk ZT, Yilmaz AS, Kalyoncu AF, Emri S, Sahin AA, Baris YI. Pulmonary symptoms and function in tea workers. Eur Respir J 1992; 5 (suppl 15): 247s.

16. Baris B, Coplu L, Emri S, Karakoca Y. Erionite-related non-mesothelial malignancies in Turkey. Eur Respir J 1993; 6 (suppl 17): 487s.

17. Emri S, Koç Y, O’brien MC, Sanders D, Tansan S, and Foss F. Taxol and arginine butyrate exert additive anti-proliferative effects on human mesothelioma cells. ASCO 1994; 13: 130.

18. Kalyoncu AF, Özyılkan E, Emri AS, Şimşek H, Çöplü L, Barış YI. The prevalences of atopy and bronchial hyperreactivity (BFR) in patients with familial Mediterranean fever (FMF). Allergy 1994; supp 2: 399s

19. Cila A, Emri S, Akhan O, Fındık S, Çöplü L, Şahin A, and Barış Yİ. MR imaging versus
CT in staging of environmental malignant pleural mesothelioma. Eur Respir J 1995; 8 (suppl 19): 370s.

20. Coplu L, Kalyoncu AF, Karakoca Y, Coplu N, Emri S, Sahin AA, Baris YI. Respiratory disorders in paper factory workers exposed to mixture of reed and straw dust. Eur Respir J 1995; 8 (suppl 19): 109s

21. Bayraktar Y, Üstündag Y, Emri S, Balkancı F, Özcebe OI, Dündar SV.Pulmonary arterial involvement in Behcet disease. Revue Du Rhumatisme. English Edition. Joint, Bone, Spine Diseases 1996; 63(No 7-8):547.

22. Üstündag Y, Emri S, Özcebe OI, Kalyoncy F, Baris YI, Dündar SV. Bronchial hyperresponsivenes in Behcet’s disease. Revue Du Rhumatisme. English Edition. Joint, Bone, Spine Diseases 1996; 63(No 7-8):557.

23. Üstündag Y, Emri S, Özcebe OI, Dündar SV, Baris YI. Severe pulmonary tuberculosis in association with Behcet’s disease. Revue Du Rhumatisme. English Edition. Joint, Bone, Spine Diseases 1996; 63(No 7-8):557.

24. Coplu L, Demir AU, Karakoca Y, Baris B, Emri S, Sahin AA, Baris YI. Mesothelioma and other malignancies due to erionite exposure in Turkey. Lung Cancer 1996; 15: 2702.

25. Coplu L, Emri S, Selcuk ZT, Bagcı AT, Fındık S, Kalyoncu F. The prevelances of cigarette smoking among the medical school students of Hacettepe University in Ankara. Eur Respir J 1998; 12 (suppl 28): 80s.

26. Köksal AŞ, Emri S, Üsküdar O. Effect of nicotine replacement therapy in quitting in a hospital base clinic of Turkiye. Eur Respir J 1999; 14 (suppl 30): 75s.

27. İnce Dİ, Dolunay N, Savcı S, Emri S, Arıkan H. Health related quality of life in patients with chronic obstructive pulmonary diseases. Eur Respir J 1999; 14 (suppl 30): 382s.

28. Bilir N, Emri S, Yıldiz AN, Demir A. Domestic exposure to biomass smoke and COPD prevalence among women in Turkey. Eur Respir J 1999; 14 (suppl 30): 485s.

29. Ertuğrul D, Köksal A, Olut A, Akçay A, Ağca E, Kirazlı S, Emri S. The diagnostic value of TNFa and TNFa receptor levels in patients with malignant pleural mesothelioma. Eur Respir J 2000; 16(suppl 31): 357s.

30. Er M, Emri S, Demir AU, Karakoca Y, Thorne PS, Bilir N, Baris YI. Prevalence of byssinosis and chronic respiratory diseases in factory workers exposed to hemp and jute in Taşköprü, a town of central Anatolia. Eur Respir J 2000; 16(suppl 31): 109s.

31. Soylu AR, Sivri B, Emri S, et al. Combined lansoprazole and cisapride therapy improves pulmonary syptoms in astmatics with gastroesophageal reflux. Gastroenterology 2001;120:A403.

32. Bagcı T, Aycengel SG, Demir AU, Bozkurt B, Öztek Z, Emri S. High levels of carboxyhemoglobin due to propane-fueled heater in Turkey. Eur Respir J 2002; 20(suppl 38): 206s.

33. Selcuk T, Ergan B, Demir AU, Cöplü L, Fırat P, Emri S, Kalyoncu F, Şahin A, Artvinli M. Overview of thoracoscopic findings between 1975 and 2000 in Hacettepe university hospital. Eur Respir J 2002; 20(suppl 38): 71s.

34. Akay H, Emri S, Kiliç D, Kadilar C, Dizbay S, Zorlu F, Baris I. The management of malignant pleural mesothelioma due to environmental exposure to erionite and asbestos in Turkey. Lung Cancer 2003; 41(suppl 2): 217s.

35. Emri S, Kiliçkap S, Kadilar C, Khalil M, Akay H, Besler T. Serum vitamin E, vitamin C, beta carotene, and retinol levels and the risk of malignant pleural mesothelioma in Turkey. Lung Cancer 2003; 41(suppl 2): 219s.

36. Pistolesi M, Symanowski J, Gatzemeier U, Emri S, Conte P, Manegold C, Levitan N, Blatter J, Paoletti P. Improving pulmonary fumction in patients with malignant pleural mesothelioma: results of the phase III trial of pemetrexed+cisplatin vs. cisplatin. Lung Cancer 2003; 41(suppl 2): 220s.

37. Carbone M, Emri S, Dogan AU, Dogan M, Steele I, Tuncer M, Baris YI. The mesothelioma epidemic in Cappadocia: The gene environment interection. Lung Cancer 2006; 54: S1

38. Emri S, Hurmuz P, Kadilar C, Cangir A, Zorlu F, Dogan R, akyol F. Pemeterxed-carboplatin doublets showed better median survival than pemeterexed-cisplatin in the treatment of Turkish malignant pleural mesothelioma patients. JOURNAL OF THORACIC ONCOLOGY 2011, 6: S1371-S1371,MEETİNG ABSTRACT

39. Esendagli D , Ozme F, Onder S , Korkmaz E , Koksal D , Emri S .The Association of HLA-DRB1*and HLA-DQB1*Alleles With the Extent and Course of Disease in Patients With Sarcoidosis CHEST 2015,Volume: 148 Issue: 4 Supplement: S Meeting Abstract: 416A DOI: 10.1378/chest.2268051

40. Emri SA, Yonar D, Sandal A, Yılmaz U, Severcan F. Differentiaition of mesothelioma from Lung Cancer and healthy individiuals using human serum by ATR-FTIR spectoroscopy coupled with chemometrics. JOURNAL OF THORACIC ONCOLOGY 2015,10:S631-S631, MEETİNG ABSTRACT p2.08.-012

41. Abbas S, Ozek NS, Koksal D, Severcan M, Emri SA, Severcan F. Infrared spectoroscopy as a novel approach in differential diagnosis of malignant pleural mesothelioma from lung cancer using pleural fluid. JOURNAL OF THORACIC ONCOLOGY 2015, 10:s350-s350, MEETİNG ABSTRACT:MINI 24.07(ORAL PRESENTATION).

42. ESENDAGLI DR, Ozturk O, Ersel D, Akduman S, Koksal D, Emri S. Short-term results of a registered smoking cessation clinic with patients referred by ALO 171 quitline. EUROPEAN RESPIRATORY JOURNAL 2014, 44: MEETİNG ABSTRACT, p4160


ISI Tarafından Taranan Uluslararası Dergilerde Yayınlanmış Makaleler

ISI tarafından taranan uluslararası dergilerde yayınlanmış 12 tane tam metin makalesi vardır.

1. Emri S, Barış B, Lheureux P, Leduc D, Yskenderany A, Seber O, and Barış YI. Carbon monoxide poisoning related to the use of stem coal in poorly ventilated bucket stoves. Eur J Emerg Med 1995; 2: 92-95.

2. Emri S, Ustundag Y, Budak T, Karakoca Y, Ozdemir O. Assessment of the value of fibronectin as a tumor marker in malignant pleural mesothelioma. Monaldi Arch Chest Dis 1997; 52: 335-338.

3. Karakoca Y, Emri S, Bagci T, Demir A, Erdem Y, Barış E, Sahin AA. Environmentally induced malignant pleural mesothelioma and HLA distribution in Turkey: Int J Tuberc Lung Dis 1998;2:1017-1022 .

4. Olut A, Ertugrul DT, Kocagoz T, Er M, Emri S. HHV-8 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma. Monaldi Arch Chest Dis 2000;55: 110-113.

5. Ozer N, Shehu V, Aytemir K, Ovunc K, Emre S, Kes S. Echocardiographic findings of pericardial involvement in patients with malignant pleural mesothelioma with a history of environmental exposure to asbestos and erionite. Respirology 2000 ;5: 333-6.

6. 6. Caglar M, Ergun E, Emri S. 99Tcm-MAA lung scintigraphy in patients with Behcet’s disease: its value and correlation with clinical course and other diagnostic modalities. Nucl Med Commun. 2000; 21: 171-9.

7. Fani Bozkurt M, Basaran Demirkazik F, Emri S, Caner B. Ventilation-perfusion lung scan and helical computed tomographic findings in a patient with behcet’s disease. Clin Nucl Med 2001; 26:721-722.

8. Olut AI, Erguven S, Emri S, Ozunlu H, Akay H. Diagnostic value of dot immunobinding assay for human pulmonary hydatidosis. Korean J Parasitol 2005; 43:15-18.

9. Emri S, Turnagül H, Basoglu S, Bacanli S, Guven GS, Aslan D. Asthma-like symptoms prevalence in five Turkish urban centers. Allergol Immunopathol(Madr) 2005;33:270-276.

10. Tug E, Tug T, Elyas H, Coskunsel M, Emri S. Tumor suppressor gene alterations in patients with malignnat mesothelioma due to environmental asbestos exposure in Turkey. J Carcinog 2006;5:23.

11. Ybarra ML, Bosi-Bağcı AT, Bilir N, Holtrop JS, Korchmaros J, Emri S. Interest in technology-based and traditional smoking cessation programs among adult smokers in Ankara, Turkey. Tobacco Induced Diseases 2011; 9:10-16.

12. Emri SA. The Cappodocia mesothelioma epidemic: its influence in Turkey and abroad. Ann Transl Med 2017;Jun;5(11):239.



ISI Tarafından Taranan Uluslararası Dergilerde Yayınlanmış Olgu Sunumları

SCISCI-EXP dışında olup, ISI tarafından taranan uluslararası dergilerde yayınlanmış 4 adet olgu Sunumu vardır.

1. Usalan C, Emri S. Membranoproliferative glomerulonephritis associated with small cell lung carcinoma. International Urology and Nephrology 1998; 30:209-213.
2. Erdogan E, Demirkazik FB, Emri S, Firat P. Organizing pneumonia after radiation therapy for breast cancer. Diagn Interv Radiol 2006;12:121-124.
3.Oz GS, Emri S, Apras BS. Development of interferon induced sarcoidosis in a patient with familial mediterranean fever. Tuberk Toraks 2008; 56: 319-324.
4. Öztürk Ö, Köksal D, Emri S. Tracheoesophageal fistula in a treatment naive patient with lung cancer. Tuberk Toraks. 2014;62(2):174-6

Diğer Hakemli Dergilerde Yayınlanmış Makale ve Takdimler

Diğer hakemli dergilerde (yurt içi ve yurt dışı) yayınlanmış makale ve takdimlerinin Sayısı 14’dür.
1. Emri S, Bayraktar Y, Arslan S, Karaağaoğlu E, Arıogul S, Kayhan B, Telatar H.HBsAg pozitif karaciger hastalıklarında delta hepatiti. Hacettepe Tıp Dergisi 1989; 22: 341-350.
2. Karaeren N, Emri S, Önde E, Alper A, Dağalp K, Karaagaoğlu E, Yılmazer I.Nicardipine’in aşağı özefagus sfinkter basıncı ve distal özefagus kontraksiyonlarına etkisi. GATA Bülteni 1991; 33: 395-404.
3. Emri S, Barış B, Kalyoncu F, Çopur AS, Şahin AA and Barış YI. Thymoma associated with leucopenia hypergammaglobulinemia and leucocytoclastic vasculitis. Eur J Int Med 1991; 2: 9-11.
4. Karakoca Y, Emri S, Cangir AK, Baris YI. Environmental pleural plaques due to asbest and fibrous zeolite exposure in Turkey. Indoor Built Environ 1997; 6: 100-105.
5. Bayraktar Y, Üstündag Y, Bayraktar M, Arslan S, Özdemir A, Emri S. Unusual manifestations of familial mediterranean fever. Turk J Gasroenterol 1997; 8: 458-463.
6. Zorlu F, Cengiz M, Emri S, Kars A, Akyol F. External radiotherapy and HDR Ir-192 brachytherapy boost in primary tracheal tumors. Turk J Cancer 2000; 30: 75-80.
7. Dogan M, Emri S. Environmental health problems related to mineral dusts in Ankara and Eskisehir, Turkey. Yerbilimleri 2000; 22: 149-161.
8. Emri S. Sigara Bırakma Yöntemleri. Hacettepe Tıp Dergisi 2002;33:10-18
9. Olut A, Emri S, derun E, Aşık M, Bozkurt B, Demir AU, Artvinli M, Günalp A. Astma and atypical bacterial infections: chlamydia pneumoniae, mycoplasma pneumoniae and legionella pneumophila. Turkish Respiratory Journal 2003; 4: 47-50.
10. Emri S, Kalyoncu F, Demircin M, Erzen C,Şahin AA, and Barış YI. A tymic cyst
with transient and spontaneous regression and false-positive cytology. JMI 1989; 3: 18-21.
11.Emri S, Zorlu F, Kisacik G, Yildirim M, Baris YI. Multiple endobronchial metastases from hemangiopericytoma with recurrent tumoral expectoration. Turk J Med Sci 1997 ; 27 : 273-275.
12. Demirkazık FB, Aksu AÖ, Cangır A, et al. Radiation-induced liver injury and foreign body reaction secondary to the diaphragmatic Teflon patch in an operated malignant pleural mesothelioma patient:CT, MRI and PET-CT findings. European Journal of Radiology Extra 2008; 66:e85-e89.
13.Tanrıover MD, Arsava BE, Emri S. Pulmonary embolisim due to metal coil:case report.(metal halkaya bağlı akciğer embolisi). Türkiye Klinikleri J Med Sci 2011;31:1551-1553.14.Yıldız O, Adıgüzel M, Cangır AK, Atasoy Ç, Emri S. Eş zamanlı allerjik bronkopulmoner aspergillozis ve mediastinal lenf nodu. Tur Toraks Der 2011; 12:114-116.


Medicana Kadıköy

Adres:

Zühtüpaşa Mahallesi, Recep Peker Caddesi. No:11 Kadıköy/İstanbul

Telefon: 0216 970 4 970
Çağrı Merkezi: 0850 460 6334